Daily non-political popular news in brief.
Protein identified that regulates effectiveness of Taxol chemotherapy in breast cancer
02-21-2007 · EurekAlert!Cancer researchers at Georgetown University Medical Center have taken a step towards understanding how and why a widely used chemotherapy drug works in patients with breast cancer.
Read more »
Keywords: protein, identified, regulates, effectiveness, taxol, chemotherapy, breast, cancer, regulate
« Previous | Next »
Similar news on "Protein identified that regulates effectiveness of Taxol chemotherapy in breast cancer":
- Researchers find docking sites for glucocorticoid receptor and Hsp90
11-20-2006 · EurekAlert!
University of Oregon researchers have identified protein interactions that regulate the response of cells to steroid hormones. The discovery, they say, could lead to new ways to boost the effectiveness and reduce undesired side effects of steroid-hormone treatments and cancer drugs.
Similar news · Read more »
- MIT radar technology fights breast cancer
11-27-2007 · EurekAlert!
Treating breast cancer with a type of heat therapy derived from MIT radar research can significantly increase the effectiveness of chemotherapy, according to results from the fourth clinical trial of the technique reported online Nov. 25 in the journal Cancer Therapy.
Similar news · Read more »
- Unsuspected protein determines resistance to breast cancer treatment
02-04-2008 · EurekAlert!
An innovative research approach has identified a previously unsuspected protein as a key player in the resistance to particular forms of breast cancer therapy...
Similar news · Read more »
- Cancer Link: Gene regulates progesterone effect on breast cells
12-02-2006 · Science News Online
The BRCA1 protein regulates the effect of pro-growth progesterone, which could explain why having a mutated
Similar news · Read more »
- Other highlights in the Dec. 6 JNCI
12-05-2006 · EurekAlert!
Other highlights in the Dec. 6 JNCI include an Italian model that predicts the risk of breast cancer, a study showing chemotherapy can cause a cognitive decline in some patients, a common genetic variant that is linked to drug-induced diarrhea, a protein that signals poor prognosis in some breast cancer patients and specific genetic changes that are linked to colon cancer in smokers.
Similar news · Read more »
- Potential new therapeutic molecular target to fight cancer
11-01-2007 · EurekAlert!
Researchers at the Virginia Commonwealth University Massey Cancer Center have identified the enzyme sphingosine kinase 2 as a possible new therapeutic target to improve the efficacy of chemotherapy for colon and breast cancer.
Similar news · Read more »
- Taxol-type drugs give slight boost to survival rates in early breast cancer
10-16-2007 · EurekAlert!
The breast cancer drugs called taxanes, which include taxol and taxotere, increase survival rates when used as part of chemotherapy following surgery for cancers that have not spread, according to a new review of the research.
Similar news · Read more »
- MIT radar technology fights breast cancer
11-28-2007 · Massachusetts Institute of Technology (MIT)
Treating breast cancer with a type of heat therapy derived from MIT radar research can significantly increase the effectiveness of chemotherapy, according to results from the fourth clinical trial of the technique reported online Nov. 25.
Similar news · Read more »
- New biomarker predicts effectiveness of breast cancer drugs
12-07-2006 · EurekAlert!
University of Cincinnati researchers have identified a new way to predict when anti-estrogen drug therapies are inappropriate for patients with hormone-dependent breast cancer.Scientists say these findings could help physicians more accurately predict which tumors will respond to anti-estrogen therapy and improve long-term survival for breast cancer patients.
Similar news · Read more »
- Jefferson researchers boost immune 'killer cells,' increase antibody effectiveness against cancer
04-18-2007 · EurekAlert!
Researchers have devised a novel method to expand the number of immune system "natural killer (NK)" cells from blood cells outside the body. They have shown in laboratory studies that adding such cells to anti-cancer therapies involving monoclonal antibody drugs such as Herceptin, which targets the HER2/neu protein on breast cancer cells, is more effective in killing cancer cells, and perhaps someday may improve treatments.
Similar news · Read more »
